NCT04978545

Brief Summary

Aim of the present study was to determine the intraradicular microbiota of previously root canal-treated teeth with apical periodontitis using droplet digital polymerase chain reaction (ddPCR) and to investigate the antibacterial effectiveness of different intracanal medicaments \[Ca(OH)2 and CHX\] that will make classical chemomechanical preparation more effective. This superiority, parallel, randomized clinical trial was conducted in the clinic of the Endodontic Department, Faculty of Dentistry, Istanbul Medipol University, Istanbul. Sixteen patients with posttreatment apical periodontitis (one tooth each) were randomly allocated into two groups according to the intracanal medicament used (n=8, for each): calcium hydroxide (CH) and 2% chlorhexidine gel (CHX) group. Total bacterial loads, as well as the amount of Enterococcus faecalis (E.faecalis) were determined before (S1) and after (S2) chemomechanical preparation and finally, after intracanal medication (S3) by means of ddPCR.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2020

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

June 28, 2021

Completed
29 days until next milestone

First Posted

Study publicly available on registry

July 27, 2021

Completed
Last Updated

October 3, 2024

Status Verified

May 1, 2023

Enrollment Period

10 months

First QC Date

June 28, 2021

Last Update Submit

October 1, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • the sequence analysis of 16S rRNA genes by the Sanger sequencing

    the Sanger sequencing

    change from baseline to postoperative 7 days

  • , the quantitation of total bacteria and E.faecalis in 5 different samples (SR1, S1, S2, SR2 and S3) taken from teeth were measured using the ddPCR

    droplet digital PCR

    change from baseline to postoperative 7 days

Study Arms (2)

calciumhydroxide

EXPERIMENTAL

Participants received calciumhydroxide as an intracanal medicament for a one week period

Other: calciumhydroxide, intracanal medicament

chlorhexidine

EXPERIMENTAL

Participants received chlorhexidine gel as an intracanal medicament for a one week period

Other: chlorhexidine, intracanal medicament

Interventions

In the CH group, calcium hydroxide powder (Calxyl; OCO Products, Dirnstein, Germany) was mixed with saline in a ratio 1:1 and the paste was inserted into the canal by using lentulo spirals (Malleifer-Dentsply).

calciumhydroxide

, chlorhexidine gel 2% (Gluco-Chex 2% gel, Cerkamed, Stalowa Wola, Polland) was placed into the root canals of this group with an Ultradent Capillary Tip (Ultradent products).

chlorhexidine

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • root canal-treated teeth exhibiting clinical and radiographic evidence of chronic apical periodontitis lesions
  • Teeth with post-treatment apical periodontitis had endodontic therapy completed more than 2 years earlier and required retreatment.
  • Radiographically, the diameter of the periapical radiolucency ranged from 2 to 7 mm.
  • Termini of the root canal fillings ranged from 0-4 mm short of the radiographic apex, with no overfilling.
  • The teeth had intact coronal restorations, with no obvious exposure of the root-filling material to the oral cavity.
  • Selected teeth had enough crown structure for adequate isolation with a rubber dam and showed an absence of periodontal pockets or attachment level deeper than 4 mm.

You may not qualify if:

  • teeth from patients who had received antibiotics within the previous 3 months or who had any general disease, teeth that could not be properly isolated with rubber dam, teeth with absence of coronary sealing, teeth with periodontal pocket depth \>4 mm; and teeth with crown/root fracture. Only one tooth was included from each patient.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Medipol University, Faculty of Dentistry

Istanbul, Esenler, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Periapical Periodontitis

Interventions

Chlorhexidine

Condition Hierarchy (Ancestors)

Periapical DiseasesJaw DiseasesStomatognathic DiseasesPeriodontal DiseasesMouth DiseasesPeriodontitis

Intervention Hierarchy (Ancestors)

BiguanidesGuanidinesAmidinesOrganic Chemicals

Study Officials

  • Seyda Ersahan, Assoc.Prof.

    IstanbulMedipol University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Microbial analysis of endodontic infections in teeth with post-treatment apical periodontitis before and after medication

Study Record Dates

First Submitted

June 28, 2021

First Posted

July 27, 2021

Study Start

January 1, 2019

Primary Completion

October 30, 2019

Study Completion

October 30, 2020

Last Updated

October 3, 2024

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will share

all collected IPD, all IPD that underlie results in a publication

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
starting 6 months after publication
Access Criteria
The investigators want to share IPD including all ddPCR results with all researchers

Locations